Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H16N2O4 |
| Molecular Weight | 276.2878 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC3(CCCC1=CC(=O)OC2=C1C(=O)NC(=O)N2)CC3
InChI
InChIKey=ARJKMWXLIHZLQZ-UHFFFAOYSA-N
InChI=1S/C14H16N2O4/c1-14(5-6-14)4-2-3-8-7-9(17)20-12-10(8)11(18)15-13(19)16-12/h7H,2-6H2,1H3,(H2,15,16,18,19)
| Molecular Formula | C14H16N2O4 |
| Molecular Weight | 276.2878 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
SCH 900271 was studied as a potent nicotinic acid receptor agonist for the Treatment of Dyslipidemia. This compound participated in a phase II clinical trial to evaluate its efficacy and safety in participants with primary hypercholesterolemia or mixed hyperlipidemia. However, apparently, the further development of SCH 900271 had been discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00941603
Participants receive SCH 900271 1-15 mg tablet and placebo tablet once daily in the morning with water in a fasted state for 8 weeks
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:20:23 GMT 2025
by
admin
on
Mon Mar 31 21:20:23 GMT 2025
|
| Record UNII |
G2283XQ6VJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
56950369
Created by
admin on Mon Mar 31 21:20:23 GMT 2025 , Edited by admin on Mon Mar 31 21:20:23 GMT 2025
|
PRIMARY | |||
|
SCH 900271
Created by
admin on Mon Mar 31 21:20:23 GMT 2025 , Edited by admin on Mon Mar 31 21:20:23 GMT 2025
|
PRIMARY | |||
|
DTXSID00238609
Created by
admin on Mon Mar 31 21:20:23 GMT 2025 , Edited by admin on Mon Mar 31 21:20:23 GMT 2025
|
PRIMARY | |||
|
G2283XQ6VJ
Created by
admin on Mon Mar 31 21:20:23 GMT 2025 , Edited by admin on Mon Mar 31 21:20:23 GMT 2025
|
PRIMARY | |||
|
300000041437
Created by
admin on Mon Mar 31 21:20:23 GMT 2025 , Edited by admin on Mon Mar 31 21:20:23 GMT 2025
|
PRIMARY | |||
|
DB12433
Created by
admin on Mon Mar 31 21:20:23 GMT 2025 , Edited by admin on Mon Mar 31 21:20:23 GMT 2025
|
PRIMARY | |||
|
915210-50-3
Created by
admin on Mon Mar 31 21:20:23 GMT 2025 , Edited by admin on Mon Mar 31 21:20:23 GMT 2025
|
PRIMARY |